On Monday, Cg Oncology Inc (NASDAQ: CGON) was -4.24% drop from the session before, before settling in for the closing price of $39.82. A 52-week range for CGON has been $14.80 – $40.65.
When this article was written, the company’s average yearly earnings per share was at -50.38%. With a float of $45.56 million, this company’s outstanding shares have now reached $76.23 million.
Cg Oncology Inc (CGON) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cg Oncology Inc stocks. The insider ownership of Cg Oncology Inc is 40.24%, while institutional ownership is 77.36%. The most recent insider transaction that took place on Sep 30 ’25, was worth 200,450. In this transaction Director of this company sold 5,000 shares at a rate of $40.09, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 29 ’25, when Company’s Director sold 12,755 for $39.19, making the entire transaction worth $499,868. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.3 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -50.38% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
You can see what Cg Oncology Inc (CGON) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 22.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5286.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.68, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach -2.37 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Looking closely at Cg Oncology Inc (NASDAQ: CGON), its last 5-days average volume was 0.91 million, which is a drop from its year-to-date volume of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 72.42%.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 85.46%, which indicates a significant increase from 49.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.68 in the past 14 days, which was higher than the 1.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.83, while its 200-day Moving Average is $27.43. However, in the short run, Cg Oncology Inc’s stock first resistance to watch stands at $39.56. Second resistance stands at $41.00. The third major resistance level sits at $41.78. If the price goes on to break the first support level at $37.34, it is likely to go to the next support level at $36.56. Now, if the price goes above the second support level, the third support stands at $35.12.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
There are 76,248K outstanding shares of the company, which has a market capitalization of 2.91 billion. As of now, sales total 1,140 K while income totals -88,040 K. Its latest quarter income was 50 K while its last quarter net income were -34,450 K.
